Stay updated with breaking news from Bio Path. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Bio-Path Holdings, Inc. (NASDAQ:BPTH – Get Free Report) was the target of a significant decline in short interest during the month of September. As of September 30th, there was short interest totalling 170,700 shares, a decline of 21.2% from the September 15th total of 216,700 shares. Based on an average daily trading volume, of 341,600 […]
Bio-Path Holdings, Inc. (NASDAQ:BPTH – Get Free Report) was the recipient of a large drop in short interest in September. As of September 30th, there was short interest totalling 170,700 shares, a drop of 21.2% from the September 15th total of 216,700 shares. Based on an average trading volume of 341,600 shares, the short-interest ratio […]
Bio-Path Holdings, Inc. (NASDAQ:BPTH – Get Free Report) was the recipient of a significant increase in short interest in September. As of September 15th, there was short interest totalling 216,700 shares, an increase of 23.1% from the August 31st total of 176,000 shares. Based on an average daily trading volume, of 340,600 shares, the short-interest […]
StockNews.com assumed coverage on shares of Bio-Path (NASDAQ:BPTH – Free Report) in a research report report published on Thursday morning. The firm issued a sell rating on the stock. Bio-Path Stock Performance NASDAQ:BPTH opened at $0.38 on Thursday. Bio-Path has a twelve month low of $0.35 and a twelve month high of $3.58. The company […]
StockNews.com began coverage on shares of Bio-Path (NASDAQ:BPTH – Free Report) in a research note published on Wednesday. The firm issued a sell rating on the stock. Bio-Path Stock Performance Bio-Path stock opened at $0.41 on Wednesday. Bio-Path has a 52 week low of $0.35 and a 52 week high of $3.85. The stock has […]